| abstract |
(57) [Summary]nCholesterol ester transport protein inhibitors having formula (I), prodrugs thereof, or pharmaceutically acceptable salts of the compounds or prodrugs, pharmaceutical compositions containing such inhibitors, and humans In some mammals to increase some plasma lipid levels, including high density lipoprotein-cholesterol, and to reduce some other plasma lipid levels, such as LDL-cholesterol and triglycerides, and Use of such inhibitors for treating diseases exacerbated by low levels of HDL cholesterol and / or high levels of LDL-cholesterol and triglycerides, such as arteriosclerosis and cardiovascular diseases. |